Literature DB >> 20131578

Cognitive versus functional approaches to rehabilitation after traumatic brain injury: commentary on a randomized controlled trial.

Gordon Muir Giles1.   

Abstract

I describe the findings of one of the largest randomized controlled trials (RCTs) of rehabilitation after traumatic brain injury (TBI) ever conducted, examine the theoretical relationship between cognitive and functional rehabilitation after TBI, and describe the historical preference for cognitive (top-down) rather than functional (bottom-up) interventions. I also contrast the goals and principles of cognitive rehabilitation and of the neurofunctional approach of Giles and Clark-Wilson (1993; Giles, 2005)--a bottom-up approach. Findings of the RCT provide empirical support for both functional and cognitive interventions following acute TBI. In addition, they provide evidence that each type of intervention offers significant advantages for a specific subpopulation. The clinical implications of these findings for occupational therapy practitioners are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20131578     DOI: 10.5014/ajot.64.1.182

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  3 in total

1.  Evaluation of autonomies in the severely brain injured: the Progression of Autonomies Scale.

Authors:  Francesco Arcuri; Lucia F Lucca; Vera Rosadini; Giuseppe Mercurio; Anna Mazzucchi
Journal:  Funct Neurol       Date:  2013 Jan-Mar

2.  Revisiting the neurofunctional approach: conceptualizing the core components for the rehabilitation of everyday living skills.

Authors:  Jo Clark-Wilson; Gordon Muir Giles; Doreen M Baxter
Journal:  Brain Inj       Date:  2014-08-25       Impact factor: 2.311

3.  Predictors of Functional Outcome in a Cohort of Hispanic Patients Using Exoskeleton Rehabilitation for Cerebrovascular Accidents and Traumatic Brain Injury.

Authors:  Lisa R Treviño; Peter Roberge; Michael E Auer; Angela Morales; Annelyn Torres-Reveron
Journal:  Front Neurorobot       Date:  2021-06-10       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.